<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[patent litigation Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/patent+litigation.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to patent litigation]]></description>
	<s:counts start="0" returned="20" found="104" />
	<language>en-us</language>
	<item>
		<title><![CDATA[FARO Technologies Inc. Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14061_23-327059.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  Operator Instructions our first question will come from the side of Mark Jordan from Noble Financial. Your line is open. Mark Jordan - Noble Financial Good morning, gentlemen and it&#8217;s nice to see things at least potentially turning in the right direction, albeit a small...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Fri, 31 Jul 2009 08:26:20 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[Patent Litigation]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/expense.html"><![CDATA[Expense]]></category>
		<category domain="http://resources.bnet.com/topic/faro+technologies+inc..html"><![CDATA[FARO Technologies Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/product+development.html"><![CDATA[Product Development]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FARO</category>
		<category domain="tickers">FARO</category>
	</item>
	<item>
		<title><![CDATA[HP and Acer Settle Patent Litigation]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_June_9/ai_n25490036]]></link>
		<description><![CDATA[PALO ALTO, Calif. -- HP (NYSE:HPQ) today announced that it has settled all ongoing patent litigation with Acer.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 09 Jun 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/acer+inc..html"><![CDATA[Acer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/hewlett-packard+co..html"><![CDATA[Hewlett-Packard Co.]]></category>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[patent litigation]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ACER</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HPQ</category>
		<category domain="tickers">ACER,HPQ</category>
	</item>
	<item>
		<title><![CDATA[AngioDynamics Announces Settlement of Patent Litigation With VNUS Medical Technologies]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_June_3/ai_n25473131]]></link>
		<description><![CDATA[QUEENSBURY, N.Y. -- AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease, announced today that it has entered into an agreement that settles all patent litigation with VNUS Medical Technologies. Under...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 03 Jun 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[patent litigation]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Enterasys Reaffirms Patent Litigation Initiatives]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200806/ai_n25479621]]></link>
		<description><![CDATA[Enterasys Networks Inc., the Secure Networks CompanyTM, today reaffirmed its commitment to a series of intellectual property portfolio initiatives that began in June of 2005.  Enterasys currently has approximately 500 patents issued worldwide and continues to aggressively protect its intellectual property rights. ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 02 Jun 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/enterasys+networks.html"><![CDATA[Enterasys Networks]]></category>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[patent litigation]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ETS</category>
		<category domain="tickers">ETS</category>
	</item>
	<item>
		<title><![CDATA[Kodak Settles Patent Litigation with St. Clair Intellectual Property Consultants]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_May_16/ai_n25431056]]></link>
		<description><![CDATA[ROCHESTER, N.Y. -- Eastman Kodak Company (NYSE:EK) today announced that it has resolved its patent dispute with St. Clair Intellectual Property Consultants, Inc.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 16 May 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/eastman+kodak+co..html"><![CDATA[Eastman Kodak Co.]]></category>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[patent litigation]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EK</category>
		<category domain="tickers">EK</category>
	</item>
	<item>
		<title><![CDATA[Sepracor Inc. Reports First Quarter 2008 Results, Certain Strategic Initiatives and Settlement of XOPENEX® Patent Litigation with Breath Limited]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_May_1/ai_n25375524]]></link>
		<description><![CDATA[Financial Highlights*]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 01 May 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[patent litigation]]></category>
		<category domain="http://resources.bnet.com/topic/sepracor+inc..html"><![CDATA[Sepracor Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SEPR</category>
		<category domain="tickers">SEPR</category>
	</item>
	<item>
		<title><![CDATA[Depomed Settles Patent Litigation Against IVAX]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_April_7/ai_n25129250]]></link>
		<description><![CDATA[Depomed to Receive $10 Million in Settlement and Royalties]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 07 Apr 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[patent litigation]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[Invitrogen, Agilent Technologies Settle Multiple Patent Litigations]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Feb_5/ai_n24249218]]></link>
		<description><![CDATA[Settlement Resolves All Pending Patent Litigations between Two Companies]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 05 Feb 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agilent+technologies+inc..html"><![CDATA[Agilent Technologies Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/invitrogen+corp..html"><![CDATA[Invitrogen Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[patent litigation]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">A</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVGN</category>
		<category domain="tickers">A,IVGN</category>
	</item>
	<item>
		<title><![CDATA[PNY Signs License Agreement With SanDisk to Settle Patent Litigation]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Jan_3/ai_n27487583]]></link>
		<description><![CDATA[MILPITAS, Calif. & PARSIPPANY, N.J. -- SanDisk Corporation (NASDAQ:SNDK) and PNY Technologies([R]) ("PNY") today announced that PNY has signed a patent cross-license agreement with SanDisk to settle patent cases filed by SanDisk last year in Federal District Court and the International Trade Commission against PNY flash memory products including USB...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 03 Jan 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/license+agreement.html"><![CDATA[license agreement]]></category>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[patent litigation]]></category>
		<category domain="http://resources.bnet.com/topic/sandisk+corp..html"><![CDATA[SanDisk Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SNDK</category>
		<category domain="tickers">SNDK</category>
	</item>
	<item>
		<title><![CDATA[The United States Patent and Trademark Office Orders the Re-Examination of Two Patents Included in the Patent Litigation between Illumina and Affymetrix]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Dec_21/ai_n27481740]]></link>
		<description><![CDATA[SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN) announced today that the United States Patent and Trademark office has ordered the re-examination of U.S. Patent Nos. 6,355,432 and 6,646,243. The serial numbers for the re-examinations are 90/008,885 and 90/008,889, respectively. They were assigned the same filing date of November 27, 2007. The...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 21 Dec 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[patent litigation]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+patent+and+trademark+office.html"><![CDATA[U.S. Patent and Trademark Office]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[The United States Patent and Trademark Office Orders The Re-Examination of Two Additional Patents Included in the Patent Litigation Between Illumina and Affymetrix]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Dec_21/ai_n27482205]]></link>
		<description><![CDATA[SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN) announced today that the United States Patent and Trademark office has ordered the re-examination of U.S. Patent Nos. 5,545,531 and 5,795,716. The serial numbers for the re-examinations are 90/008,888 and 90/008,886, respectively. They were assigned the same filing date of November 27, 2007. The...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 21 Dec 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[patent litigation]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+patent+and+trademark+office.html"><![CDATA[U.S. Patent and Trademark Office]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[ImClone and Sanofi-Aventis Settle Patent Litigation with Yeda Research and Development Corporation]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Dec_7/ai_n27469134]]></link>
		<description><![CDATA[NEW YORK -- ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel cancer therapeutics, today announced that it has signed a settlement agreement with Yeda Research and Development Company Ltd. and Sanofi-Aventis to end worldwide litigation related to U.S. Patent No. 6,217,866 (the "866...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 07 Dec 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[patent litigation]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi-aventis.html"><![CDATA[Sanofi-Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[CIBA Vision, the eye care unit of Novartis, announces settlement of patent litigation with CooperVision, Inc.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200711/ai_n21111363]]></link>
		<description><![CDATA[* Companies to cross-license rights to contact lens innovations ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 21 Nov 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[patent litigation]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[Ronald A. Katz Technology Licensing, L.P. Announces the Settlement of Patent Litigation with Express Scripts, Inc]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Nov_7/ai_n27435897]]></link>
		<description><![CDATA[LOS ANGELES -- Ronald A. Katz Technology Licensing, L.P., headquartered in Los Angeles, announces the settlement of patent litigation with Express Scripts, Inc., based in St. Louis, MO. As part of the settlement, Express Scripts, Inc. has agreed to pay an undisclosed sum for a nonexclusive license under a comprehensive...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 07 Nov 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/express+scripts+inc..html"><![CDATA[Express Scripts Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[patent litigation]]></category>
		<category domain="http://resources.bnet.com/topic/settlement.html"><![CDATA[settlement]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ESRX</category>
		<category domain="tickers">ESRX</category>
	</item>
	<item>
		<title><![CDATA[Ronald A. Katz Technology Licensing, L.P. Announces the Settlement of Patent Litigation with Target Corporation]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Nov_7/ai_n27436192]]></link>
		<description><![CDATA[LOS ANGELES -- Ronald A. Katz Technology Licensing, L.P., headquartered in Los Angeles, announces that it has settled patent litigation with Target Corporation headquartered in Minneapolis. As part of the settlement, Target Corporation has agreed to pay an undisclosed sum for a nonexclusive license under a comprehensive portfolio of patents...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 07 Nov 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[patent litigation]]></category>
		<category domain="http://resources.bnet.com/topic/target+corp..html"><![CDATA[Target Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TGT</category>
		<category domain="tickers">TGT</category>
	</item>
	<item>
		<title><![CDATA[Sky Technologies' Patent Litigation Case Against Ariba Set for Trial]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200710/ai_n21071877]]></link>
		<description><![CDATA[A Massachusetts Federal District Court Judge yesterday denied  Ariba, Inc.'s  (NASDAQ: ARBA) request for summary judgment in a patent infringement lawsuit brought by Boston-based  Sky Technologies , sending the case to a jury trial on December 3, 2007 in Federal District Court for the District of Massachusetts. ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 31 Oct 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/ariba+inc..html"><![CDATA[Ariba Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[patent litigation]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ARBA</category>
		<category domain="tickers">ARBA</category>
	</item>
	<item>
		<title><![CDATA[ev3 Inc. Announces Agreements in Principle to Settle Patent Litigation]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Oct_31/ai_n27427620]]></link>
		<description><![CDATA[PLYMOUTH, Minn. -- ev3 Inc. (NASDAQ:EVVV), today announced that the company and its subsidiaries reached agreements in principle to resolve patent infringement and other litigation with The Regents of the University of California and Boston Scientific Corporation. Products involved in the litigation include embolic protection devices and certain detachable embolic...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 31 Oct 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agreement.html"><![CDATA[agreement]]></category>
		<category domain="http://resources.bnet.com/topic/litigation.html"><![CDATA[litigation]]></category>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[patent litigation]]></category>
		<category domain="http://resources.bnet.com/topic/university+of+california.html"><![CDATA[University of California]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Transmeta Announces Settlement of Patent Litigation, Technology Transfer and License Agreement with Intel]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Oct_24/ai_n27418648]]></link>
		<description><![CDATA[SANTA CLARA, Calif. -- Transmeta Corporation (NASDAQ: TMTA) today announced that it has reached an agreement with Intel to settle all claims between them and to license the Transmeta patent portfolio to Intel for use in current and future Intel products.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 24 Oct 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/intel+corp..html"><![CDATA[Intel Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/license+agreement.html"><![CDATA[license agreement]]></category>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[patent litigation]]></category>
		<category domain="http://resources.bnet.com/topic/transmeta+corp..html"><![CDATA[Transmeta Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INTC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TMTA</category>
		<category domain="tickers">INTC,TMTA</category>
	</item>
	<item>
		<title><![CDATA[Roche Considering Legal Options In Patent Litigation Case]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Oct_23/ai_n27417404]]></link>
		<description><![CDATA[NUTLEY, N.J. -- Roche announced today that a jury in the U.S. District Court in Massachusetts found in favor of Amgen in the patent infringement dispute relating to the Roche erythropoiesis-stimulating agent, MIRCERA[R] . Roche is currently evaluating its legal options, including the possibility of an appeal.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 23 Oct 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[patent litigation]]></category>
		<category domain="http://resources.bnet.com/topic/roche+holding+ag.html"><![CDATA[Roche Holding AG]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Vonage Holdings and Klausner Technologies Settle Patent Litigation]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Oct_11/ai_n27404871]]></link>
		<description><![CDATA[Vonage Enters License Agreement with Klausner for VOIP Voicemail]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 11 Oct 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[patent litigation]]></category>
		<category domain="http://resources.bnet.com/topic/vonage+holdings+corp..html"><![CDATA[Vonage Holdings Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VG</category>
		<category domain="tickers">VG</category>
	</item>
</channel>
</rss>
